Surgical Automations
Surgical Automations is a Dallas-based, pre-clinical medical device company developing the Vāsuki Robotic System, an AI-guided autonomous endoscopic robot that automates critical steps in gastrointestinal endoscopy for hospitals and gastroenterology practices.
- Company typePrivate
- Founded2023
- HeadquartersDallas, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Surgical Automations does
Surgical Automations is a Dallas-based, privately held medical device company founded in 2023 and operating in stealth mode. It is developing the Vāsuki Robotic System, an AI-guided autonomous endoscopic robot designed to automate critical steps during gastrointestinal (GI) endoscopy procedures. The system combines AI, robotics, and advanced sensing to improve procedural safety and consistency, with the company explicitly targeting hospitals, gastroenterology practices, and ambulatory surgical centers as end users.
The company's technology is centered on a single product platform — the Vāsuki Robotic System — described as leveraging advanced AI-guided automation and precision engineering to transform endoscopy. Specific technical architecture (sensor modalities, autonomy stack, data flywheel, regulatory pathway) is not publicly disclosed. The Vāsuki mark is registered as a trademark. As of October 2025 the company is pre-clinical, with early human testing on its roadmap.
Surgical Automations has not yet commercialized a product and is pre-revenue. Its future revenue model is expected to follow standard enterprise medical device mechanics — direct sales or leasing of capital robotic systems to hospitals and gastroenterology departments, with associated service and maintenance contracts. The company has raised approximately $4.2M cumulatively, including a $3.4M oversubscribed seed round in October 2025 co-led by Dr. Fred Moll (Intuitive Surgical co-founder) and TurboStart, with prior non-dilutive support from MedTech Innovator in 2024. The leadership team comprises CEO and founder Sanket Chauhan, co-founder Jason Blackstone, and co-founder & COO Ritambhara Agrawal.
Surgical Automations firmographics
Firmographics- Name
- Surgical Automations
- Legal name
- Surgical Automations
- Website
- https://autosurg.com
- Company type
- Private
- Founded year
- 2023
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Surgical Automations is a Dallas-based, pre-clinical medical device company developing the Vāsuki Robotic System, an AI-guided autonomous endoscopic robot that automates critical steps in gastrointestinal endoscopy for hospitals and gastroenterology practices.
- Ownership category
- akta.pro rank
Surgical Automations industry classification
Industry- Product category
- Surgical Robotics
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Computer Systems Design Services (541512)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Services-Computer Integrated Systems Design (7373)
- akta.pro primary industry
- Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)
- akta.pro secondary industries
- Healthcare & Assistive Robotics (HDAAAIAC), Operating Room Integration & Surgical Informatics (OR control, documentation, connectivity) (HLAHADAE), Surgical, Perioperative & ERAS Pathway Tools (HLACAGAJ)
Keywords
Where Surgical Automations is headquartered
LocationHeadquarters
- HQ city
- Dallas
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Surgical Automations business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Medical Device Sales (Future): Surgical Automations is currently in stealth mode developing its Vāsuki Robotic System. The company has not yet generated revenue. Future revenue will likely derive from selling or leasing surgical robotic systems to hospitals and gastroenterology practices, potentially accompanied by recurring service and maintenance contracts typical of medical device companies.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
Surgical Automations product offering
Product offeringCore offering
Surgical Automations is developing the Vāsuki Robotic System, an AI-guided autonomous endoscopic robot for gastrointestinal (GI) procedures. The system combines advanced AI, robotics, and precision engineering to automate critical endoscopic steps, aiming to improve procedural safety, reduce outcome variability, and enhance physician control. The company is currently in stealth mode and has not yet commercialized the product.
Product overview
Surgical Automations offers a single unified product — the Vāsuki Robotic System — an AI-driven autonomous endoscopic robot designed for gastrointestinal procedures. The system combines robotics and AI to automate endoscopic steps, improving patient outcomes and procedural safety. No additional modules, add-ons, or related product lines are referenced in available sources.
Differentiator
Problem solved
Functional benefit
Brands
- Vāsuki: Vāsuki™ Robotic System - an AI-guided autonomous endoscopic robot for gastrointestinal endoscopy procedures, leveraging advanced AI guided automation and precision engineering to transform endoscopy.
Products and services
- Vāsuki Robotic System
Companies that use Surgical Automations
Customer profileSegments1 record
Ideal customer profiles1 record
Surgical Automations technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Surgical Automations partnerships and signals
Strategic signalScale indicators2 records
Recent moves5 records
Expansion highlights4 records
Surgical Automations competitors and assessment
Company assessmentDirect peers
- EndoQuest Robotics: EndoQuest Robotics is developing a flexible robotic endoscopy platform that uses a robotic controller to navigate and perform procedures in the GI tract. Most direct comparable to Surgical Automations' Vāsuki system in target anatomy, robotic approach, and clinical use case.
- Auris Health (Johnson & Johnson): Auris Health, now part of J&J MedTech, pioneered robotic endoscopy with the Monarch platform (initially bronchoscopy, expanding to urology and other indications). Closest large-player precedent for autonomous endoscopic robotics and a primary competitive threat to Vāsuki in adjacent indications.
- Noah Medical: Noah Medical builds the Ion robotic bronchoscopy system for lung endoscopy, using AI-driven navigation to automate diagnosis. Highly comparable technology stack (AI + robotics + endoscopy) and comparable mission of automating critical steps in flexible endoscopic procedures.
Broad incumbents
- Intuitive Surgical: Intuitive Surgical is the dominant surgical robotics company (da Vinci platform) and the benchmark for the industry. Dr. Fred Moll's involvement with Surgical Automations directly links the company to Intuitive's commercial playbook, though Intuitive itself does not currently address GI endoscopy with da Vinci.
- Olympus Corporation: Olympus is the global leader in flexible GI endoscopes and endoscopy informatics, with the largest installed base in hospitals worldwide. The most important incumbent Surgical Automations must displace or partner with for Vāsuki to reach the GI endoscopy market.
- Medtronic: Medtronic's Endoscopy Operating Unit (GI Genius, PillCam, breath diagnostics) is investing heavily in AI-augmented GI endoscopy. A likely incumbent competitor if autonomous endoscopy becomes commercially attractive.
- Boston Scientific: Boston Scientific has a large GI endoscopy franchise (single-use scopes, hemostasis, resection tools) and has been actively adding AI and robotics capabilities. Represents both a potential channel partner and a competitive incumbent for autonomous GI systems.
- Stryker: Stryker has meaningful endoscopy/surgical visualization and robotics exposure (Mako for ortho robotics, growing endoscopy business). A broad incumbent with the capital and channel to enter autonomous GI endoscopy if the category matures.
Emerging players
- Vicarious Surgical: Vicarious Surgical is developing a next-generation robotic surgical system combining virtual reality and AI. Comparable in being an early-stage public surgical robotics company pursuing autonomous features, though focused on laparoscopic rather than endoscopic indications.
- Virtual Incision: Virtual Incision is developing the MIRA miniaturized robotic-assisted surgery platform for general surgery and other endoscopic/laparoscopic procedures. Comparable in being a smaller surgical robotics company targeting minimally invasive procedures with potential applicability to GI indications.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights5 records
Customer concentration
Surgical Automations financial estimates
Financial estimateRevenue estimate
Valuation estimate
Surgical Automations leadership team
Management profileNumber of profiles
Profiles3 records
Surgical Automations funding detail
Funding detailFunding overview
Funding rounds3 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Surgical Automations M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Surgical Automations
What does Surgical Automations do?
Surgical Automations is developing the Vāsuki Robotic System, an AI-guided autonomous endoscopic robot for gastrointestinal (GI) procedures. The system combines advanced AI, robotics, and precision engineering to automate critical endoscopic steps, aiming to improve procedural safety, reduce outcome variability, and enhance physician control. The company is currently in stealth mode and has not yet commercialized the product.
Is Surgical Automations a public or private company?
Surgical Automations is a private company. It is classified as venture growth investor backed and is currently operating.
When was Surgical Automations founded?
Surgical Automations was founded in 2023. It employs 1 to 10 people.
Where is Surgical Automations based?
Surgical Automations is headquartered in Dallas, United States, in the North America region.
How does Surgical Automations make money?
One revenue line is on record: medical Device Sales (Future).
Who are Surgical Automations's main competitors?
Direct peers on record are EndoQuest Robotics, Auris Health (Johnson & Johnson) and Noah Medical. Broad incumbents are Intuitive Surgical, Olympus Corporation, Medtronic, Boston Scientific and Stryker. Emerging players are Vicarious Surgical and Virtual Incision.
Does Surgical Automations have an API?
No public API is recorded for Surgical Automations.
What industry is Surgical Automations in?
Surgical Automations's product category is Surgical Robotics. Its primary akta.pro industry code is HLAHADAF, Surgical Robotics & Computer-Assisted Surgery Platforms, with a secondary code of HDAAAIAC, Healthcare & Assistive Robotics. Its NAICS code is 339112 and its SIC code is 3841.